63 results
Page 2 of 4
424B5
y3kfxv8hjz6822rpoon
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
z2ncbjsu5839q8kyt da
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.1
nhewt
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-1.1
kxa8s4q3thcph
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
echutyfp2wply
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
opwot25k p7
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
e725 7wp4pdkp
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.6
77f7htdh epw
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.5
rtkgpakvue
14 Dec 20
Automatic shelf registration
4:02pm
8-K
c8hvwgee
14 Dec 20
Regulation FD Disclosure
7:30am
8-K
g5n5li3s65k
29 May 20
Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTACĀ® Protein Degrader
7:06am